Far-field bioluminescent immune cell-mediated photodynamic therapy is limited by photon flux.
No detectable ROS generation or tumor cell cytotoxicity in vitro is observed using luciferase-engineered tumor-associated macrophages and verteporfin, and complementary Monte Carlo simulations show that achievable photon fluxes are several orders of magnitude below established thresholds for cytotoxic PDT.